EFPIA - NEWSLETTER

EFPIA Newsletter 28 October 2021

News

28 October 2021 Joint Industry Statement: ABPI, EFPIA, Farmindustria, IMC, IFPMA, JPMA, LEEM, PhRMA, vfa

UN Climate Change Conference (COP26): Biopharmaceutical Industry Actions to Tackle Climate Change

28 October 2021 Supporting academic and non-for-profit champions to repurpose medicines

The EMA and several National Competent Authorities launch a new pilot project today

27 October 2021 Good Lay Summary Practice Recommendations are now published in EudraLex.

Recognising the importance of providing accessible and understandable summaries of clinical trial results to patients...

Blogs

27 October 2021 Fitting vaccine research into one year – Were animals used?

A blog by EFPIA and Vaccines Europe

27 October 2021 #EUnited against inequalities in Cancer care

From the EU Beating Cancer Plan to the countries where patients live and receive care

28 October 2021 Living with cancer after cancer (Guest Blog)

We as a society are all responsible for comprehensive inclusion and return of cancer patients to normal life after treatment...

Making the impossible, possible

Finding personalised solutions for each person living with allergies

Precision medicine can make it possible to find personalised solutions for each person living with allergies, thus improving quality of life

Pushing the boundaries of science

Every journey begins with a question. The urge to find the answer drives us to search for new ways to push the boundaries of science to make the impossible, possible to change people’s lives for the better and #WeWontRest

Events

08 NOV 2021

Global Pharmaceutical and Biotechnology Conference Virtual event

Sustaining innovation and collaboration beyond the pandemic #FTPharma

Learn more →

09 NOV 2021

Investigating the syndemic threat of COVID-19 and chronic disease: The diabetes case... Virtual event

Improved integration of care is the way forward to strengthen chronic disease management in emergencies and beyond

Learn more →

09 NOV 2021

Joint EFPIA & EFGCP “Good Lay Summary Practice” Recommendations Virtual event

The new tool you should use to comply with the European Clinical Trial Regulation (EU No. 536/2014)

Learn more →

16 NOV 2021

Pandemic Prevention: how Europe can lead the fight against AMR Virtual event

The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not.

Learn more →

What we are reading

EU Hits 75% COVID-19 Vaccine Uptake 19 October 2021 (Vaccines Today)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶